Antipsychotic use up among U.S. medicaid-enrolled youth

Antipsychotic use up among U.S. medicaid-enrolled youth
There has been a substantial increase in antipsychotic use among Medicaid-enrolled children in recent years, with the increase partially driven by youth with attention-deficit/hyperactivity disorder and those with multiple diagnoses, according to a study published online Sept. 4 in Health Services Research.

(HealthDay)—There has been a substantial increase in antipsychotic use among Medicaid-enrolled children in recent years, with the increase partially driven by youth with attention-deficit/hyperactivity disorder (ADHD) and those with multiple diagnoses, according to a study published online Sept. 4 in Health Services Research.

Meredith Matone, M.H.S., from the Children's Hospital of Philadelphia, and colleagues used Medicaid Analytic Extract files for 50 states and the District of Columbia to describe the relationship between mental health diagnosis and treatment with in children from 2002 to 2007.

The researchers found that there was a 62 percent increase in antipsychotic use, reaching 354,000 youth by 2007. Proportionally, youth with bipolar disorder, schizophrenia, and autism were more likely to receive antipsychotics, while the largest consumers of antipsychotics over time were youth with and those with three or more mental health diagnoses. By 2007, 50 percent of total antipsychotic use was for youth with ADHD and one in seven antipsychotic users were youth with a sole diagnosis of ADHD.

"This national analysis revealed persistent growth in second-generation antipsychotic use among U.S. -enrolled children during the past decade," the authors write. "In the context of a complex relationship between childhood behavior, diagnosis, and treatment, future research will need to more broadly examine the efficacy and safety of second-generation antipsychotic use in pediatric populations and the potential consequences of efforts to restrict their use."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

More kids taking antipsychotics for ADHD: study

Aug 07, 2012

(HealthDay) -- Use of powerful antipsychotic medications such as Abilify and Risperdal to control youngsters with attention-deficit/hyperactivity disorder (ADHD) and other behavior problems has skyrocketed ...

Recommended for you

Brains transform remote threats into anxiety

Nov 21, 2014

Modern life can feel defined by low-level anxiety swirling through society. Continual reports about terrorism and war. A struggle to stay on top of family finances and hold onto jobs. An onslaught of news ...

Mental disorders due to permanent stress

Nov 21, 2014

Activated through permanent stress, immune cells will have a damaging effect on and cause changes to the brain. This may result in mental disorders. The effects of permanent stress on the immune system are studied by the ...

Could there be a bright side to depression?

Nov 21, 2014

(Medical Xpress)—A group of researchers studying the roots of depression has developed a test that leads them closer to the idea that depression may actually be an adaptation meant to help people cope with ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.